Health Catalyst Inc's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 148/482 in the Software & IT Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 3.94.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Health Catalyst Inc's Score
Industry at a Glance
Industry Ranking
148 / 482
Overall Ranking
232 / 4582
Industry
Software & IT Services
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
12
analysts
Hold
Current Rating
3.944
Target Price
+49.41%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Health Catalyst Inc Highlights
StrengthsRisks
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Overvalued
The company’s latest PE is -1.48, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 55.72M shares, decreasing 19.01% quarter-over-quarter.
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Ticker SymbolHCAT
CompanyHealth Catalyst Inc
CEO
Websitehttps://www.healthcatalyst.com/
FAQs
What is the current price of Health Catalyst Inc (HCAT)?
The current price of Health Catalyst Inc (HCAT) is 2.460.
What is the symbol of Health Catalyst Inc?
The ticker symbol of Health Catalyst Inc is HCAT.
What is the 52-week high of Health Catalyst Inc?
The 52-week high of Health Catalyst Inc is 8.000.
What is the 52-week low of Health Catalyst Inc?
The 52-week low of Health Catalyst Inc is 2.015.
What is the market capitalization of Health Catalyst Inc?
The market capitalization of Health Catalyst Inc is 173.73M.
What is the net income of Health Catalyst Inc?
The net income of Health Catalyst Inc is -69.50M.
Is Health Catalyst Inc (HCAT) currently rated as Buy, Hold, or Sell?
According to analysts, Health Catalyst Inc (HCAT) has an overall rating of Hold, with a price target of 3.944.
What is the Earnings Per Share (EPS TTM) of Health Catalyst Inc (HCAT)?
The Earnings Per Share (EPS TTM) of Health Catalyst Inc (HCAT) is -1.584.